Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GrekTek is a private digital health and medical device company focused on cardiac monitoring and remote patient management. The company developed the Everbeat platform, previously branded HealthyWatch, which combines wearable sensing, mobile applications, and clinician-facing software to help detect, monitor, and manage heart conditions including atrial fibrillation and other arrhythmias. GrekTek has also offered telehealth and chronic care management tools that collect daily patient-generated data such as blood pressure, weight, medications, and symptoms for provider review. Its newer product direction centers on the everbeat ring and a planned cardiac monitoring patch intended to provide medical-grade ECG-based heart monitoring and support future FDA clearance. The company appears to be an early-stage healthcare technology business rather than a traditional therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GrekTek.